Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival

EMBO Journal

Volumn 15, Issue 24, 1996, Pages 7070-7078

  Zimber Strobl, Ursula ^a   Kempkes, Bettina ^a   Marschall, Gabriele ^a   Zeidler, Reinhard ^a   Van Kooten, Cees ^b   Banchereau, Jacques ^b   Bornkamm, Georg W ^a   Hammerschmidt, Wolfgang ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

B cell immortalization; CD40; Epstein Barr virus; Latent membrane protein 1

Indexed keywords

CD40 ANTIGEN; CELL NUCLEUS ANTIGEN; TRANSCRIPTION FACTOR; VIRUS ENVELOPE PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL VIABILITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

EID: 0030465535     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1460-2075.1996.tb01098.x     Document Type: Article

References (62)

1. Baichwal,V.R. and Sugden,B. (1988) Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene, 2, 461-467.
2. Banchereau,J. and Rousset,F. (1991) Growing human B lymphocytes in the CD40 system. Nature, 353, 678-679.
3. Banchereau,J., de Paoli,P., Valle,A., Garcia,E. and Rousset,F. (1991) Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science, 251, 70-72.
4. Brielmeier,M., Mautner,J., Laux,G. and Hammerschmidt,W. (1996) Latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. J. Gen. Virol., in press.
5. Calender,A., Billaud,M., Aubry,J.P., Banchereau,J., Vuillaume,M. and Lenoir,G.M. (1987) Epstein-Barr virus (EBV) induces expression of B cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Natl Acad. Sci. USA, 84, 8060-8084.
6. Cheng,G. and Baltimore,D. (1996) TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-κB activation. Genes Dev., 10, 963-973.
7. Cheng,G., Cleary,A.M., Ye,Z.S., Hong,D.I., Lederman,S. and Baltimore,D. (1995) Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science, 267, 1494-1498.
8. Cohen,J.I., Wang,F., Mannick,J. and Kieff,E. (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl Acad. Sci. USA, 86, 9558-9562.
9. Cordier,M. et al. (1990) Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B cell activation molecules CD21 and CD23. J. Virol., 64, 1002-1013.
10. Craig,F.E., Gulley,M.L. and Banks,P.M. (1993) Posttransplantation lymphoproliferative disorders. Am. J. Clin. Pathol., 99, 265-276.
11. Dawson,C.W., Rickinson,A.B. and Young,L.S. (1990) Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature, 344, 777-780.
12. Fahraeus,R., Jansson,A., Ricksten,A., Sjoeblom,A. and Rymo,L. (1990a) Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl Acad. Sci. USA, 87, 7390-7394.
13. Fahraeus,R., Rymo,L., Rhim,J.S. and Klein,G. (1990b) Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature, 345, 447-449.
14. Farrell,P.J. (1995) Epstein-Barr virus immortalizing genes. Trends Microbiol., 3, 105-109.
15. Fennewald,S., van Santen,V. and Kieff,E. (1984) Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol., 51, 411-419.
16. Galibert,L., Burdin,N., de Saint-Vis,B., Garrone,P., Van Kooten,C., Banchereau,J. and Rousset,F. (1996) CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med., 183, 77-85.
17. Grossman,S.R., Johannsen,E., Tong,X., Yalamanchili,R. and Kieff,E. (1994) The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jκ recombination signal binding protein. Proc. Natl Acad. Sci. USA, 91, 7568-7572.
18. Hammarskjoeld,M.L. and Simurda,M.C. (1992) Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J. Virol., 66, 6496-6501.
19. Hammerschmidt,W. and Sugden,B. (1989) Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature, 340, 393-397.
20. Hammerschmidt,W., Sugden,B. and Baichwal,V.R. (1989) The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol., 63, 2469-2475.
21. Henderson,S., Rowe,M., Gregory,C., Croom,C.D., Wang,F. and Longnecker,R. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell, 65, 1107-1115.
22. Henkel,T., Ling,P.D., Hayward,S.D. and Peterson,M.G. (1994) Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science, 265, 92-95.
23. Huen,D.S., Henderson,S.A., Croom-Carter,D. and Rowe,M. (1995) The Epstein-Barr virus latent membrane protein-1 (LMPI) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene, 10, 549-560.
24. Kaye,K.M., Izumi,K.M. and Kieff,E. (1993) Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl Acad. Sci. USA, 90, 9150-9154.
25. Kempkes,B., Pich,D., Zeidler,R., Sugden,B. and Hammerschmidt,W. (1995a) Immortalization of human B-lymphocytes by a plasmid containing 71 kpb of Epstein-Barr viral DNA. J. Virol., 69, 231-238.
26. Kempkes,B., Spitkovsky,D., Jansen-Dürr,P., Ellwart,J.W., Delecluse, H.-J., Rottenberger,C., Kremmer,E., Bornkamm,G.W. and Hammerschmidt,W. (1995b) B cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J., 14, 88-96.
27. Kempkes,B., Zimber-Strobl,U., Eissner,G., Pawlita,M., Falk,M., Hammerschmidt,W. and Bornkamm,G.W. (1996) Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines. J. Gen. Virol., 77, 227-237.
28. Knutson,J.C. (1990) The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B cell immortalization. J. Virol., 64, 2530-2536.
29. Laherty,C.D., Hu,H.M., Opipari,A.W., Wang,F. and Dixit,V.M. (1992) The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor κB. J. Biol. Chem., 267, 24157-24160.
30. Laux,G., Adam,B., Strobl,L.J. and Moreau-Gachelin,F. (1994a) The Spi1/PU. I and Spi-B ets family transcription factors and the recombination signal binding protein RBP-Jκ interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element. EMBO J., 13, 5624-5632.
31. Laux,G., Dugrillon,F., Eckert,C., Adam,B., Zimber-Strobl,U. and Bornkamm,G.W. (1994b) Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J. Virol., 68, 6947-6958.
32. Liebowitz,D., Wang,D. and Kieff,E. (1986) Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol., 58, 233-237.
33. Ling,P.D., Rawlins,D.R. and Hayward,S.D. (1993) The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl Acad. Sci. USA, 90, 9237-9241.
34. Lowe,S.W., Ruley,H.E., Jacks,T. and Housman,D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
35. Mannick,J.B., Cohen,J.I., Birkenbach,M., Marchini,A. and Kieff,E. (1991) The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol., 65, 6826-6837.
36. Martin,J.M., Veis,D., Korsmeyer,S.J. and Sugden,B. (1993) Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J. Virol., 67, 5269-5278.
37. Miller, G. (1990) Epstein-Barr virus. Biology, pathogenesis and medical aspects. In Fields, B.N. and Knipe, D.M. (ed.), Virology. Raven Press, New York, NY, pp. 1921-1958.
38. Mitchell,T. and Sugden,B. (1995) Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol., 69, 2968-2976.
39. Moorthy,R.K. and Thorley-Lawson,D.A. (1993) All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J. Virol., 67, 1638-1646.
40. Mosialos,G., Birkenbach,M., Yalamanchili,R., VanArsdale,T. Ware,C. and Kieff,E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
41. Mosmann,T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
42. O'Connor,M., Peifer,M. and Bender,W. (1989) Construction of large DNA segments in Escherichia coli. Science, 244, 1307-1312.
43. Pallesen,G., Hamilton-Dutoit,S.J. and Zhou,X. (1993) The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field. In Advances in Cancer Research. Academic Press, New York, NY, pp. 179-239.
44. Peng,M. and Lundgren,E. (1992) Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene, 7, 1775-1782.
45. Rabson,M., Gradoville,L., Heston,L. and Miller,G. (1982) Nonimmortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye. J. Virol., 44, 834-844.
46. Rothe,M., Wong,S.C., Henzel,W.J. and Goeddel,D.V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell, 78, 681-692.
47. Rothe,M., Sarma,V., Dixit,V.M. and Goeddel,D.V. (1995) TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science, 269, 1424-1427.
48. Rousset,F., Garcia,E. and Banchereau,J. (1991) Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med., 173, 705-710.
49. Rowe,M., Peng-Pilon,M., Huen,D.S., Hardy,R., Croom-Carter,D., Lundgren,E. and Rickinson,A.B. (1994) Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMPI: a B cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J. Virol., 68, 5602-5612.
50. Sugden,B., Marsh,K. and Yates,J. (1985) A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell. Biol., 5, 410-413.
51. Sung,N.S., Kenney,S., Gutsch,D. and Pagano,J.S. (1991) EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J. Virol., 65, 2164-2169.
52. Tomkinson,B., Robertson,E. and Kieff,E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67, 2014-2025.
53. Waltzer,L., Logeat,F., Brou,C., Israel,A., Sergeant,A. and Manet,E. (1994) The human Jκ recombination signal sequence binding protein (RBP-Jκ) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements. EMBO J., 13, 5633-5638.
54. Wang,D., Liebowitz,D. and Kieff,E. (1985) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell, 43, 831-840.
55. Wang,F., Gregory,C., Sample,C., Rowe,M., Liebowitz,D., Murray,R., Rickinson,A. and Kieff,E. (1990) Epstein-Barr virus latent membrane protein (LMPI) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMPI cooperatively induce CD23. J. Virol., 64, 2309-2318.
56. Wang,F., Gregory,C.D., Rowe,M., Rickinson,A.B., Wang,D., Birkenbach,M., Kikutani,H., Kishimoto,T. and Kieff,E. (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B cell activation antigen CD23. Proc. Natl Acad. Sci. USA, 84, 3452-3456.
57. Wilson,J.B., Weinberg,W., Johnson,R., Yuspa,S. and Levine,A.J. (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell, 61, 1315-1327.
58. Yates,J., Warren,N., Reisman,D. and Sugden,B. (1984) A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl Acad. Sci. USA, 81, 3806-3810.
59. Zeng,Y. et al. (1985) Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int. J. Cancer, 36, 545-547.
60. Zimber-Strobl,U., Suentzenich,K.O., Laux,G., Eick,D., Cordier,M., Calender,A., Billaud,M., Lenoir,G.M. and Bornkamm,G.W. (1991) Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol., 65, 415-423.
61. Zimber-Strobl,U., Kremmer,E., Graesser,F., Marschall,G., Laux,G. and Bornkamm,G.W. (1993) The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J., 12, 167-175.
62. Zimber-Strobl,U., Strobl,L.J., Meitinger,C., Hinrichs,R., Sakai,T., Furukawa,T., Honjo,T. and Bornkamm,G.W. (1994) Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jκ, the homologue of Drosophila Suppressor of Hairless. EMBO J., 13, 4973-4982.